Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders. - Wikidata - wikimedia - TriplyDB

Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders.

Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders.

http://www.wikidata.org/entity/Q34015933

about

Generation of Tolerogenic Dendritic Cells and Their Therapeutic Applications Therapeutic Potential of Hyporesponsive CD4(+) T Cells in Autoimmunity The neuropeptide vasoactive intestinal peptide: direct effects on immune cells and involvement in inflammatory and autoimmune diseases Regulatory dendritic cells for immunotherapy in immunologic diseases CD4+ T Cell-derived Novel Peptide Thp5 Induces Interleukin-4 Production in CD4+ T Cells to Direct T Helper 2 Cell Differentiation Peripheral blood CD8αα+CD11c+MHC-II+CD3- cells attenuate autoimmune glomerulonephritis in rats.Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism.VIP-expressing dendritic cells protect against spontaneous autoimmune peripheral polyneuropathy.Dendritic cells transduced with lentiviral vectors expressing VIP differentiate into VIP-secreting tolerogenic-like DCs.Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions.How tolerogenic dendritic cells induce regulatory T cells Identification of a bone marrow-derived CD8αα+ dendritic cell-like population in inflamed autoimmune target tissue with capability of inducing T cell apoptosis Characterization of regulatory dendritic cells that mitigate acute graft-versus-host disease in older mice following allogeneic bone marrow transplantation.Therapeutic effect of vasoactive intestinal peptide on experimental autoimmune encephalomyelitis: down-regulation of inflammatory and autoimmune responses.Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same?Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis.Natural recovery from antiglomerular basement membrane glomerulonephritis is associated with glomeruli-infiltrating CD8α+CD11c+MHC class II+ cells.Vasoactive intestinal peptide induces regulatory dendritic cells that prevent acute graft-versus-host disease while maintaining the graft-versus-tumor response.Regulation of dendritic cell differentiation by vasoactive intestinal peptide: therapeutic applications on autoimmunity and transplantation.Tuning inflammation with anti-inflammatory neuropeptides.Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disorders Immunoregulatory dendritic cells to prevent and reverse new-onset Type 1 diabetes mellitus.Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy.Protected graft copolymer excipient leads to a higher acute maximum tolerated dose and extends residence time of vasoactive intestinal Peptide significantly better than sterically stabilized micelles.Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disorders.Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory disease.Regulation of the mucosal phenotype in dendritic cells by PPARγ: role of tissue microenvironment.Adrenomedullin protects from experimental autoimmune encephalomyelitis at multiple levels.Development of dendritic cell-based immunotherapy for autoimmunity.Treating arthritis by immunomodulation: is there a role for regulatory T cells?Dendritic cell-based therapy in Type 1 diabetes mellitus.Novel findings in drug-induced dendritic cell tolerogenicity.Neuropeptides as pleiotropic modulators of the immune response.Tolerogenic dendritic cells and rheumatoid arthritis: current status and perspectives.Stem cell therapy for multiple sclerosis: preclinical evidence beyond all doubt?Dendritic cells: cellular mediators for immunological tolerance T regulatory cells in childhood arthritis--novel insights.The Enteric Network: Interactions between the Immune and Nervous Systems of the Gut.The Complement Inhibitor Factor H Generates an Anti-Inflammatory and Tolerogenic State in Monocyte-Derived Dendritic Cells.

P2860

Q26764855-1FE43891-44A0-4D52-B163-DFFB3DEFC8B5 Q26781243-315D4F45-78AA-46E5-B1F2-E93DA1872837 Q26851670-76C9BF0A-364E-4433-9F71-0293C53F3D51 Q26866216-7451E1E4-9F2A-4631-BD93-E66D18176A8E Q27675896-DA44B5A7-AE57-4C9A-A4B1-DB5F123BB034 Q33560830-1B6E02D9-6CA5-42E3-A9DC-FD2043E42E0A Q33685495-13F21CEE-3E62-41EA-AC66-BE10D7E324B3 Q33763653-0F724650-A976-4CF8-B9D5-5CA7769FD453 Q33870752-AD1B8AD9-D758-4955-B98C-A132B16494B9 Q33931602-902F5334-0310-4617-BFBF-9E446093EA4F Q34238010-A2F1A596-6A2B-4A14-810C-D7E3BD3AE1D3 Q34631825-9823CB35-6071-4CA7-A835-4C1DB8505BAD Q34769555-8C2391E8-B9D4-41B5-9BF2-229BAD5ADBF6 Q34990554-D29DAE0E-B759-459F-8FB9-82D1B37F1C13 Q35088106-C6BDDA39-C71A-4723-9B05-960E3A0C67AF Q35116303-75A44034-8A72-4A23-8A54-8DBFE012BEFB Q35295564-D30096DD-2FC8-4A75-ACAE-3DF5C48FF587 Q35610719-4679E06D-32B3-45CB-B167-0FD2845402D8 Q35849658-2978BF49-C833-40CD-8317-005DEEB547D7 Q36693973-0507DE12-AD95-4717-852B-ACA7110F71F2 Q36764912-0348F2AC-23C9-4818-8C3A-7E163123F614 Q36830470-7F6E8833-E1C1-40CB-9C04-B3058711330E Q36897372-EB0D384A-EDC6-4FB5-BAC7-C70F18309B92 Q36969911-EFB90AA2-4A94-46B0-9001-5693D4BF69EB Q37074087-AA5BAF6F-856F-409F-919A-1E1F36DFD05C Q37191369-C2EDFD48-9B9C-4FA2-8BFD-845BFCA75A39 Q37552024-1D311BBF-9988-4011-B872-0384F61B8AA9 Q37581433-049A6277-660B-466B-9B73-05DB276BD880 Q37633526-216B6E2A-FB1C-4950-9B46-44260E92A8BD Q37701864-003B34DC-480B-4E9A-A24B-C1A3A0483FEA Q37750140-D42F2309-C6DC-4DBB-A350-34C777F2BFDA Q37754644-83CCE4CC-FDD8-498F-B088-0FA8A948DD66 Q37809070-9318C68D-4156-48BA-897B-3FA7E61F406E Q37898396-F7FE300E-1A08-4EB6-8A5D-301F72B63CE0 Q37929646-BC42F8EB-0969-4C99-8000-181D481F9174 Q37991400-595AA3EF-431C-48CA-8086-AE7AE126A3DD Q38114071-B78CB780-0692-4C59-AC68-1FAB2C0F5738 Q38167815-0C60A465-455A-48F7-B522-6AB09898F7BE Q39388328-27623E97-8F1A-4BFF-AE1C-BCF5D3285AFA Q40715358-901CEFED-482C-454F-8788-D851718DAEB8

P2860

Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders.

http://www.wikidata.org/entity/Q34015933

description

2005 nî lūn-bûn

@nan

2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Vasoactive intestinal peptide ...... fects on autoimmune disorders.

@ast

Vasoactive intestinal peptide ...... fects on autoimmune disorders.

@en

Vasoactive intestinal peptide ...... fects on autoimmune disorders.

@nl

type

label

Vasoactive intestinal peptide ...... fects on autoimmune disorders.

@ast

Vasoactive intestinal peptide ...... fects on autoimmune disorders.

@en

Vasoactive intestinal peptide ...... fects on autoimmune disorders.

@nl

prefLabel

Vasoactive intestinal peptide ...... fects on autoimmune disorders.

@ast

Vasoactive intestinal peptide ...... fects on autoimmune disorders.

@en

Vasoactive intestinal peptide ...... fects on autoimmune disorders.

@nl

P1433

Q34015933-CD0DC275-4D55-4FC5-B480-E9FB52E00AC2

P1476

Q34015933-266FF1D4-D1BA-42C9-871C-D8DFB5E97293

P2093

Q34015933-0C0B9FC8-05C5-4741-8DE3-D4CB8D8584DB

Q34015933-8C7388FF-9420-4549-A7F2-BBCCE1D54872

Q34015933-F93C20F7-EFC6-4F78-B117-049DDAF3C9FC

P2860

Q34015933-0A908F94-3FA2-4035-8C5C-8D452F7ADAE8

Q34015933-174B2371-731A-4D48-87E4-33CE3111EA24

Q34015933-18083D14-3417-48C2-B7AD-5F51B7DD9B66

Q34015933-2DE86EB5-0F86-4E63-A1F7-25ADAC75C2F4

Q34015933-30046AF2-8899-4ABC-952C-5DDBF1415CBC

Q34015933-4147A76C-4AD6-4604-8C90-895B1498B687

Q34015933-45C0C697-F317-4638-9F47-62E52A28E8EE

Q34015933-46CD91FD-2A35-4758-91E2-C954AA58CD59

Q34015933-47C2C196-3D1E-427A-8C72-D84F6F83DB41

Q34015933-4C9B0DB8-A805-46E6-8618-F25B598A1F76

P304

Q34015933-A7EC000F-A0CA-4F12-8736-DDB626833BE1

P31

Q34015933-41F6A4CC-1137-488E-8AE7-5E7614446D07

P356

Q34015933-6129A125-CEA5-4800-BFB0-A5D9C3A76392

P407

Q34015933-BCB6490C-6616-4BF6-AE67-57122ADDFCB9

P433

Q34015933-3F120137-548D-4CD7-A649-2B1CA8A5E067

P478

Q34015933-0BA016A6-5932-473B-8B1B-89477007D9F7

P50

Q34015933-6F918ECD-FDE3-4240-92D3-0993502C2AAA

Q34015933-832D37C0-73D0-4663-A359-48388C644720

Q34015933-FC311932-ECF2-4FE5-AC21-DF99B796C444

P577

Q34015933-FBF2A7EA-819E-4545-BF56-B67E27D06695

P5875

Q34015933-E1BAAA8D-24AD-4911-B279-06BD0D63D3AA

P698

Q34015933-5A58C317-3A4A-4B00-86B4-ECA1CC581D25

P932

Q34015933-5F5AB870-7AC4-449E-840B-F7DDB4FA021E

P356

PNAS.0504484102

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Vasoactive intestinal peptide ...... ffects on autoimmune disorders

@en

P2093

Amelia Fernandez-Martin

http://www.w3.org/2001/XMLSchema#string

David Pozo

http://www.w3.org/2001/XMLSchema#string

Doina Ganea

http://www.w3.org/2001/XMLSchema#string

P2860

Immunobiology of dendritic cells

Tolerogenic dendritic cells

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo

VIPase autoantibodies in Fas-defective mice and patients with autoimmune disease.

The role of CD40 in peripheral T cell tolerance and immunity.

Differentiation of T regulatory cells by immature dendritic cells.

The significance of vasoactive intestinal peptide in immunomodulation.

Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance.

P304

13562-13567

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0504484102

http://www.w3.org/2001/XMLSchema#string

P407

P433

38

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

Elena Gonzalez-Rey

P577

2005-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7610851

http://www.w3.org/2001/XMLSchema#string

P698

16150720

http://www.w3.org/2001/XMLSchema#string

P932

1224633

http://www.w3.org/2001/XMLSchema#string